Head-to-head · WeighScore
NuDay Rx vs Rixa Health
The verdict
NuDay Rx takes it — 66.9/100 to 60.5/100.
NuDay Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuDay Rx is a GLP-1 weight-loss telehealth service (on the CareValidate/careGLP platform) that pairs medication with video coaching and lifestyle support.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | NuDay Rx | Rixa Health |
|---|---|---|
| WeighScore | 66.9/100 | 60.5/100 |
| Grade | C | C |
| Scorecard rank | #182 | #321 |
| Semaglutide | $249/mo (compounded) | Not disclosed |
| Tirzepatide | $329/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #182 · C
Strengths
- Wide selection — compounded semaglutide ($249) and tirzepatide ($329), oral tablet options, plus brand GLP-1 (cash pay)
- Includes video coaching and lifestyle support with a licensed-doctor consult
- Full legal suite published (Terms, Privacy, Privacy Practices, Medical Consent)
- Prescription delivered to your door after an online intake and consult
Where it loses points
- Compounded semaglutide ($249) is pricier than some budget competitors
- Compounding pharmacy partner not named
- Not LegitScript-certified (no certification displayed)
- Runs on a shared white-label telehealth platform (CareValidate/careGLP)
Graded #321 · C
Strengths
- Functional-medicine, root-cause clinical approach
- Compounded and oral semaglutide plus tirzepatide offered
- Board-certified DO and FNP providers with years of experience
- Medication bundled with visits into a single price
- No charge until after approval
Where it loses points
- No public monthly pricing; quoted only during consultation
- Relies on compounded GLP-1, which is not FDA-approved as a finished drug
- A handful of states still listed as coming soon
- Branded GLP-1 medications are not the primary offering
- Requires ongoing monthly follow-up commitment
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.